STAT Plus: Biotech venture capital had a record-breaking quarter, but isn’t out of the woods yet
ADOBE
Biotech venture capital had a record-breaking first quarter — but the full impact of the coronavirus pandemic remains to be seen.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario